PepsiCo to focus on value, healthier offerings amid slump in snacks
CEO Ramon Laguarta said the Doritos maker hasn’t seen a “direct impact” from GLP-1 medications despite higher consumer interest in health and wellness.


CEO Ramon Laguarta said the Doritos maker hasn’t seen a “direct impact” from GLP-1 medications despite higher consumer interest in health and wellness.